Latest Advances

  • Condition: Polyarticular Juvenile Idiopathic Arthritis
  • Journal: RMD open
  • Treatment Used: Adalimumab with or without Methotrexate
  • Number of Patients: 171
  • Published —
The study researched the outcomes of adalimumab with or without methotrexate for polyarticular juvenile idiopathic arthritis.
  • Condition: Monogenic Autoinflammatory Diseases and PFAPA Syndrome
  • Journal: Frontiers in immunology
  • Treatment Used: anti-IL-1 agents and other biologic drugs
  • Number of Patients: 0
  • Published —
This review analyzed the treatment of the most frequent monogenic autoinflammatory diseases.
  • Condition: Late Acute Cellular Rejection in Kidney Transplant Patient
  • Journal: Iranian journal of kidney diseases
  • Treatment Used: Anakinra
  • Number of Patients: 1
  • Published —
This case report describes a 49-year-old woman with a history of kidney transplantation who developed a late acute cellular rejection after anakinra treatment.
  • Condition: Pediatric Patients with Colchicine-Resistant Familial Mediterranean Fever (FMF)
  • Journal: International journal of rheumatic diseases
  • Treatment Used: Anti-Interleukin-1 Treatment (anti-IL-1)
  • Number of Patients: 25
  • Published —
This study evaluated the effect of anti-interleukin-1 (anti-IL-1) treatment on quality of life in pediatric patients with colchicine-resistant familial Mediterranean fever (hereditary inflammatory disorder; FMF).
  • Condition: Pediatric Rheumatic Diseases
  • Journal: The Turkish journal of pediatrics
  • Treatment Used: Canakinumab
  • Number of Patients: 29
  • Published —
In this study, researchers evaluated the outcomes of using canakinumab for the treatment of pediatric rheumatic diseases.
  • Condition: Familial Mediterranean Fever
  • Journal: The American journal of case reports
  • Treatment Used: Physiological Glucocorticoids
  • Number of Patients: 0
  • Published —
This case report describes a Japanese patient with familial Mediterranean fever and adrenocorticotropic hormone deficiency who was non-compliant with hydrocortisone replacement therapy.
  • Condition: Colchicine-Resistant Familial Mediterranean Fever
  • Journal: Rheumatology international
  • Treatment Used: Tofacitinib
  • Number of Patients: 0
  • Published —
The study researched the outcomes of tofacitinib for treating colchicine-resistant familial Mediterranean fever.
  • Condition: Familial Mediterranean Fever
  • Journal: The American journal of case reports
  • Treatment Used: Medical Cannabis
  • Number of Patients: 2
  • Published —
This case reported on two patients with familial Mediterranean fever treated with medical cannabis.
  • Condition: Recipients of Kidney Transplant With Familial Mediterranean Fever (FMF)
  • Journal: Transplantation proceedings
  • Treatment Used: Canakinumab
  • Number of Patients: 4
  • Published —
This case series presented experience with patients with familial Mediterranean fever (FMF) and end-stage renal disease who were colchicine- resistant and on other alternative therapies, which provided poor disease control.
  • Condition: Familial Mediterranean Fever (FMF) with Amyloidosis
  • Journal: Medical hypotheses
  • Treatment Used: IL-1 Blockers and Colchicine as First Line Therapy
  • Number of Patients: 0
  • Published —
This article discusses the treatment of familial Mediterranean fever (FMF) with amyloidosis with the first line therapy of IL-1 blockers combined with colchicine.
Showing 1-12 of 22